a screaming buy, page-2

First 2 Last

Share
Profile

Follow
Blane66

2,524 Posts.

69

02/05/16

13:31

Post #: 17652312
Share

Originally posted by Maxineamillion ↑

Well, I'm only half way through my list of ASX biotech stocks, but I am yet to find one other biotech company that is trading below cash backing (yet alone well below cash backing) and there are so many companies on that list that I would consider 'junk' stock or 'scam' stocks.

So far I have looked at approximately 35 companies. I'll continue my search and let you know whether I find another one.

In the meantime, I'm calling this a screaming buy for new investors. The old ones are probably well and truly over it.

Keep in mind too that BLT are still owed around $5m in R&D tax refund due shortly and their cash burn will be around half what it has been in the last year due to ceasation of the TT-034 trial.

I find it incredible that this is trading where it is when BLT have 3 near term clinical programs.

Expand

Too true, Max. With AMD, it would be the trifecta of pre-clinical programs. The question then is, if they start a Hep B trial, they have the possibility of starting at a higher dose, and they also wouldn't need that many patients to prove it works either, since they would hopefully hit the therapeutic sooner.

BLT Price at posting: 11.0¢ Sentiment: Hold Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

Week 29 Wrap: ASX hits new all time high of 8,766pts ahead of Aug 1

SYR

Syrah jumps +19% as graphite tariff threat spurs optimism down under

SER

Strategic Energy extends its QLD copper-gold frontier with Diamantina acquisition

BDM

Burgundy plunges -20% after turning to layoffs to navigate record-low diamond prices

STN

Saturn brings up seventh straight Apollo Hill upgrade on 'impressive' 300-hole drill run

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

AII

A new NASDAQ listing for a key player in the global critical minerals space

PSC

Prospect's Mumbezhi Project puts it at the middle of copper's megatrend. And FQM just bought in

DRO

History repeats for DroneShield investors but carnage so far subdued

HotCopper Highlights: Trigg; Droneshield; Lumos & more

First 2 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

a screaming buy, page-2

Top Stories

Week 29 Wrap: ASX hits new all time high of 8,766pts ahead of Aug 1

Syrah jumps +19% as graphite tariff threat spurs optimism down under

Strategic Energy extends its QLD copper-gold frontier with Diamantina acquisition

Burgundy plunges -20% after turning to layoffs to navigate record-low diamond prices

Saturn brings up seventh straight Apollo Hill upgrade on 'impressive' 300-hole drill run

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

A new NASDAQ listing for a key player in the global critical minerals space

Prospect's Mumbezhi Project puts it at the middle of copper's megatrend. And FQM just bought in

History repeats for DroneShield investors but carnage so far subdued

HotCopper Highlights: Trigg; Droneshield; Lumos & more

Featured News